Kevin Horgan, MD, Appointed CMO of Soligenix, Inc. (SNGX.OB)
Located in Princeton, New Jersey, Soligenix has earned a reputation as a late-stage biopharmaceutical company developing products to treat life-threatening side effects of cancer treatments and serious gastrointestinal diseases. Today, the young company took a major step towards prominence with the announcement that Kevin Horgan, MD, has been appointed the company’s Senior Vice President and Chief Medical Officer. Dr. Horgan brings with him a distinguished career of over 25 years of excellence in both the industry and the field of academia. Dr. Horgan has over 40 publications in peer-reviewed journals including the New England Journal of Medicine, Nature, Journal of…